Latest filing published 29 Mar 2021 for Idera Pharmaceuticals, INC., €5,735.
Filing timeline
BuySaleInsider track record
Elizabeth Ann Tarka: trading record in brief
Elizabeth Ann Tarka is a declared insider of Idera Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 10 January 2020 to 25 March 2021.
No open-market purchase appears, only 2 sales worth €12k. The rest of the record consists of 1 share grant. 2021 to date brings no purchases and 2 sales.
The latest filing, published on 29 March 2021, reports an open-market sale of €5,735 in Idera Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Elizabeth Ann Tarka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,018 shares@ US$1.3548.8% of flowCommon StockSEC:0001415889-21-001674:0
- 1,745 shares@ US$4.1951.2% of flowCommon StockSEC:0001179110-21-000562:0
- 20,000 shares0Common StockSEC:0001179110-20-000566:0
3 of 3 declarations